Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report

被引：0
|
作者：
Margaret R. Warner
Anne M. Wolka
Rebecca A. Noel
机构：
[1] Eli Lilly and Company,Lilly Research Laboratories
[2] Lilly Corporate Center,undefined
来源：
Therapeutic Innovation & Regulatory Science | 2016年 / 50卷
关键词：
benefit-risk assessment; Periodic Benefit-Risk Evaluation Report (PBRER); periodic safety update report (PSUR); benefit-risk framework; International Conference on Harmonisation (ICH);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：342 / 346
页数：4
相关论文
共 50 条
  • [1] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Warner, Margaret R.
    Wolka, Anne M.
    Noel, Rebecca A.
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (03) : 342 - 346
  • [2] Evaluation of Benefit-Risk
    Garattini, Silvio
    [J]. PHARMACOECONOMICS, 2010, 28 (11) : 981 - 986
  • [3] Evaluation of Benefit-Risk
    Silvio Garattini
    [J]. PharmacoEconomics, 2010, 28 : 981 - 986
  • [4] Benefit-risk assessment of vaccines
    Kochhar, Sonali
    Izurieta, Hector S.
    Chandler, Rebecca E.
    Hacker, Adam
    Chen, Robert T.
    Levitan, Bennett
    [J]. VACCINE, 2024, 42 (04) : 969 - 971
  • [5] Structured benefit-risk evaluation for medicinal products: review of quantitative benefit-risk assessment findings in the literature
    Kurzinger, Marie-Laure
    Douarin, Ludivine
    Uzun, Ievgeniia
    El-Haddad, Chantal
    Hurst, William
    Juhaeri, Juhaeri
    Tcherny-Lessenot, Stephanie
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
  • [6] Estimand in benefit-risk assessment
    Ren, Xinru
    Chen, X. Gregory
    Seifu, Yodit
    Wang, William
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2023, 33 (04) : 452 - 465
  • [7] BENEFIT-RISK ASSESSMENT TODAY
    HALL, RE
    [J]. JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1978, 55 (01) : 193 - 197
  • [8] Periodic Benefit-Risk Evaluation Report: A European Union Regulatory Perspective
    Arlett P.
    Postigo R.
    Janssen H.
    Spooner A.
    [J]. Pharmaceutical Medicine, 2014, 28 (6) : 309 - 315
  • [9] Practical dilemmas in implementing benefit-risk protocols
    Louis K. Wagner
    [J]. Pediatric Radiology, 2002, 32 : 238 - 241
  • [10] Practical dilemmas in implementing benefit-risk protocols
    Wagner, LK
    [J]. PEDIATRIC RADIOLOGY, 2002, 32 (04) : 238 - 241
12345